By Tanya Agrawal
(Reuters) - U.S. stocks ticked lower on Tuesday, with the Dow industrials weighed by companies reporting earnings while the Nasdaq gained on the back of a proposed merger in the biotech sector.
Travelers
Dupont was down 2.6 percent at $70.92 and IBM fell 1 percent to $164.41.
"I think the market has just written off the first-half of the year," said Aaron Jett, vice president of global equity research at Bel Air Investment Advisors in Los Angeles.
"We're just waiting for the dust to settle with the strong dollar and the oil prices and nobody really knows what the effects will be."
More From This Section
The dollar <.DXY> is up almost 9 percent since the beginning of the year against a basket of major currencies. A strong dollar hurts companies with large overseas operations.
Other companies such as United Technologies
At 11:48 a.m. EDT (1548 GMT) the Dow Jones industrial average <.DJI> was down 76.18 points, or 0.42 percent, at 17,958.75 and the S&P 500 <.SPX> was down 3.25 points, or 0.15 percent, at 2,097.15, while the Nasdaq Composite <.IXIC> was up 20.46 points, or 0.41 percent, at 5,015.06.
Mylan
Just 42.2 percent of the S&P 500 components that have reported earnings so far have beaten revenue estimates, compared with the 58 percent average top-line beat over the last year.
Almost 73 percent have beat bottom-line expectations, according to Thomson Reuters data.
Travelers reported a 21 percent fall in quarterly net profit and its shares fell 2.8 percent to $103.13.
Dow component Verizon
Earnings expected later on Tuesday include Chipotle
Advancing issues outnumbered declining ones on the NYSE by 1,492 to 1,416, for a 1.05-to-1 ratio on the upside; on the Nasdaq, 1,424 issues rose and 1,181 fell for a 1.21-to-1 ratio favouring advancers.
The benchmark S&P 500 index was posting 9 new 52-week highs and no new lows; the Nasdaq Composite was recording 77 new highs and 19 new lows.
(Reporting by Tanya Agrawal; Editing by Savio D'Souza)